Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of LipoCol Forte vs Lovastatin in Healthy Subjects
NCT01527669Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2012
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of LipoCol Forte in hypercholesterolemia (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Pharmacokinetic parameters of lovastatin and lovastatin acid at 1 week. Started Feb 2012; status: completed.
02
Drugs
LipoCol Forte
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01527669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527669.